reduc estim reflect
reiter outperform
chang model made chang model reflect analysi
potenti impact coronaviru ew major busi reduc ep
estim
respect also reduc sale estim
respect reflect organ growth respect
previou estim despit rapidli evolv natur
outbreak uncertainti regard scope durat effect
view analysi framework reason guid potenti rang effect
ew comfort point base case scenario reflect new
estim middl rang lower target price
reiter outperform rate ew
new estim reflect base case assumpt across rang risk
factor analysi contempl potenti impact defer procedur
procedur less deferr capit equip flu care diagnost
busi line also take account geograph exposur ew major
busi china apac ex-china ou ex-apac us final consid
potenti rang durat may see pressur slowdown variou
busi base case assumpt durat impact last
recaptur percentag lost defer
procedur period end market stabil addit detail
analysi behind estim chang pleas see correspond sector updat
estim cut reduc estim includ
addit background
valuat target price base ev/ebitda
multipl previous bil ebitda estim bil
risk product delay unexpect share loss potenti litig regulatory/qu
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
global manufactur provid
medic devic equip structur valvular heart diseas
critic care
one-year valuat scenario base
ev/ebitda ebitda
one-year valuat grey scenario base
ev/ebitda grey ebitda
 close
chang model
figur chang model
compani mention price
matt miksic certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
